Temporal dynamics in laboratory medicine: cosinor analysis and real-world data (RWD) approaches to population chronobiology

被引:0
|
作者
Marques-Garcia, Fernando [1 ]
Martinez-Bravo, Cristina [1 ]
Tejedor-Ganduxe, Xavier [1 ]
Fossion, Ruben [2 ,3 ]
机构
[1] Germans Trias I Pujol Univ Hosp, Clin Biochem Dept, Metropolitan Nord Clin Lab LUMN, Barcelona 08916, Spain
[2] Natl Autonomous Univ Mexico UNAM, Inst Nucl Sci, Mexico City, Mexico
[3] Natl Autonomous Univ Mexico UNAM, Ctr Complex Syst C3, Mexico City, Mexico
关键词
population chronobiology; cosinor; data clouds; population-averaged profiles; HEALTHY-YOUNG MALES; PARAMETERS; BISPEBJERG; RHYTHMS; TIME;
D O I
10.1515/cclm-2024-1198
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives Chronobiology is the science that studies biological rhythms based on direct methods and empirical time series of individual subjects. In laboratory medicine, the factor of time is often underestimated, and no methods currently exist to study biological rhythms in population databases of point-like, real-world data (RWD).Methods Retrospective databases (24 months, 2022-2023) were extracted for four measurands (sodium, potassium, chloride and leukocytes) from the emergency laboratory. Two different strategies for data grouping were applied: data clouds (with or without outliers) and population-averaged profiles. Cosinor regression analysis was performed on the grouped data to derive circadian parameters. The parameters obtained here were compared to results from the literature, using direct methods and time series.Results A total of 409,719 data points were analyzed. All measurands exhibited symmetrical data distributions, except for leukocytes. The data clouds did not visually display rhythmicity, but cosinor analysis revealed a significant circadian rhythm. The removal of outliers had minimal impact on the results. In contrast, population-averaged profiles showed visible rhythmicity, which was confirmed by cosinor analysis with a better goodness-of-fit compared to the data clouds.Conclusions Population-averaged profiles have advantages over data clouds in characterizing circadian rhythms and deriving circadian parameters. Population chronobiology, based on RWD, is presented as an alternative to classical individual chronobiology, based on time series and overcomes the limitations of direct methods. Utilizing RWD provides new insights into the relationship between chronobiology and clinical laboratory practice.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Gender Differences in CKD Progression: Real-World Data (RWD) Analysis
    Stavas, Joseph
    Filler, Guido
    Irwin, Debra E.
    Lovett, Kate
    Shah, Rohan J.
    Butler, Emily L.
    Ferris, Maria E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 573 - 573
  • [2] Data processing and analysis in real-world traditional Chinese medicine clinical data: challenges and approaches
    Liu, Baoyan
    Zhou, Xuezhong
    Wang, Yinhui
    Hu, Jingqing
    He, Liyun
    Zhang, Runshun
    Chen, Shibo
    Guo, Yufeng
    STATISTICS IN MEDICINE, 2012, 31 (07) : 653 - 660
  • [3] REAL-WORLD DATA (RWD) AND INNOVATIVE DECENTRALIZED APPROACHES - PUTTING THE PATIENT FIRST AND ENHANCING PATIENT DIVERSITY
    Henderson, J.
    Proulx, K.
    Fillingham, S.
    Gwadry-Sridhar, F.
    VALUE IN HEALTH, 2023, 26 (06) : S410 - S410
  • [4] Investigating racial differences in treatment responses through analysis of real-world data (RWD).
    Liu, Zongzhi
    Ma, Meng
    Grover, Kartikey
    Li, Li
    Goldsweig, Howard
    Yadav, Kamlesh
    Zhou, Xiang
    Mullaney, Tommy
    Redfern, Arielle
    Jappe, Whitney
    Zimmerman, Michelle
    Prentice, Tony
    Pan, Qi
    Oh, William K.
    Schadt, Eric E.
    Li, Dan
    Chen, Rong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] The availability of laboratory data in real-world data and association of temporal and patient factors
    Dillon, Paul
    Arnold, Phil
    Chaudhary, Nayan
    Flahavan, Evelyn M.
    Meyer, Anne-Marie
    Davies, Jessica
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 324 - 325
  • [6] UNDERSTANDING USE OF REAL-WORLD DATA (RWD) AND REAL-WORLD EVIDENCE (RWE) TO SUPPORT EFFECTIVENESS LABELING CHANGES
    Mercon, K.
    Eckert, J. C.
    Mahendraratnam, N.
    Kroetsch, A. F.
    Wosinska, M.
    McClellan, M.
    VALUE IN HEALTH, 2020, 23 : S384 - S384
  • [7] DEVELOPMENT OF REAL-WORLD DATA AND THE USE OF RWD FOR EVIDENCE GENERATION IN CHINA
    Cai, B.
    Xie, Y.
    Gong, Y.
    Luo, W.
    Qu, H.
    Liu, J.
    VALUE IN HEALTH, 2019, 22 : S389 - S390
  • [8] EXPERIENCE IN IMPLEMENTING CLINICAL TRIAL TO REAL-WORLD DATA (RWD) LINKAGE
    NajafZadeh, M.
    Saunders, D.
    Demirci, S.
    Niamathullah, S.
    Vaccaro, T.
    McConnochie, B.
    Polewaczyk, J.
    Tyagi, A.
    Ahmed, A.
    Oromendia, A.
    VALUE IN HEALTH, 2024, 27 (06) : S393 - S393
  • [9] Incorporating external real-world data (RWD) in confirmatory adaptive design
    Lin, Junjing
    Lin, Jianchang
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (06) : 805 - 817
  • [10] Methodological approaches to the use of real-world data(RWD) for medical products to treat breast cancer: An FDA oncology center of excellence evaluation of RWD submissions
    Royce, Melanie E.
    Lee, Jennifer J.
    Osgood, Christy L.
    Amiri-Kordestani, Laleh
    Beaver, Julia A.
    Kluetz, Paul G.
    Rivera, Donna R.
    CANCER RESEARCH, 2022, 82 (04)